Brochures are available in Adobe Acrobat (PDF) format.
Please fill out the user profile form.
If you experience any problems downloading this information, please contact David Cunningham at firstname.lastname@example.org or tel: 781-972-5472.
(Open Researcher and Contributor ID) is a nonproprietary alphanumeric code to uniquely identify scientific and other academic authors and contributors.
August 31 – September 1
Display of Antibodies
Antibodies for Cancer Therapy
Improving Immunotherapy Efficacy and Safety
Characterization for Novel Biotherapeutics
Immunogenicity Case Studies and Clinical Management
Emerging Indications for Therapeutic Antibodies
Advancing Bispecific Antibodies and Combination Therapy to the Clinic
CAR Ts, TCRs and TILs
Optimizing Protein Expression
Immunogenicity Assessment and Regulatory Approval of Biologics
Engineering Antibody-Drug Conjugates
Engineering Bispecific Antibodies
Clinical Progress of Antibody-Drug Conjugates
Agonist Immunotherapy Targets
Cell and Gene Therapy Analytics
Protein Expression System Engineering
Optimizing Bioassays for Biologics